Literature DB >> 27402153

Non-invasive prediction of catheter ablation outcome in persistent atrial fibrillation by fibrillatory wave amplitude computation in multiple electrocardiogram leads.

Vicente Zarzoso1, Decebal G Latcu2, Antonio R Hidalgo-Muñoz3, Marianna Meo4, Olivier Meste3, Irina Popescu2, Nadir Saoudi2.   

Abstract

BACKGROUND: Catheter ablation (CA) of persistent atrial fibrillation (AF) is challenging, and reported results are capable of improvement. A better patient selection for the procedure could enhance its success rate while avoiding the risks associated with ablation, especially for patients with low odds of favorable outcome. CA outcome can be predicted non-invasively by atrial fibrillatory wave (f-wave) amplitude, but previous works focused mostly on manual measures in single electrocardiogram (ECG) leads only. AIM: To assess the long-term prediction ability of f-wave amplitude when computed in multiple ECG leads.
METHODS: Sixty-two patients with persistent AF (52 men; mean age 61.5±10.4years) referred for CA were enrolled. A standard 1-minute 12-lead ECG was acquired before the ablation procedure for each patient. F-wave amplitudes in different ECG leads were computed by a non-invasive signal processing algorithm, and combined into a mutivariate prediction model based on logistic regression.
RESULTS: During an average follow-up of 13.9±8.3months, 47 patients had no AF recurrence after ablation. A lead selection approach relying on the Wald index pointed to I, V1, V2 and V5 as the most relevant ECG leads to predict jointly CA outcome using f-wave amplitudes, reaching an area under the curve of 0.854, and improving on single-lead amplitude-based predictors.
CONCLUSION: Analysing the f-wave amplitude in several ECG leads simultaneously can significantly improve CA long-term outcome prediction in persistent AF compared with predictors based on single-lead measures.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Ablation par cathéter; Amplitude des ondes de fibrillation atriale; Atrial fibrillation; Catheter ablation; Electrocardiography; Fibrillation atriale; Fibrillatory wave amplitude; Prédiction du suivi; Therapy outcome prediction; Électrocardiographie

Mesh:

Year:  2016        PMID: 27402153     DOI: 10.1016/j.acvd.2016.03.002

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  5 in total

1.  Coarse fibrillatory waves in atrial fibrillation predict success of electrical cardioversion.

Authors:  Tian X Zhao; Claire A Martin; John P Cooper; Parag R Gajendragadkar
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-12-22       Impact factor: 1.468

2.  Relationship between coarse F waves and thromboembolic events in patients with permanent atrial fibrillation.

Authors:  Yahya Kemal İçen; Hasan Koca; Hilmi Erdem Sümbül; Arafat Yıldırım; Fadime Koca; Abdullah Yıldırım; Mustafa Lutfullah Ardıc; Mükremin Coşkun; Mehmet Uğurlu; Mevlüt Koç
Journal:  J Arrhythm       Date:  2020-09-02

3.  Fibrillatory Wave Amplitude Evolution during Persistent Atrial Fibrillation Ablation: Implications for Atrial Substrate and Fibrillation Complexity Assessment.

Authors:  Fabien Squara; Didier Scarlatti; Sok-Sithikun Bun; Pamela Moceri; Emile Ferrari; Olivier Meste; Vicente Zarzoso
Journal:  J Clin Med       Date:  2022-08-03       Impact factor: 4.964

4.  Surface ECG-based complexity parameters for predicting outcomes of catheter ablation for nonparoxysmal atrial fibrillation: efficacy of fibrillatory wave amplitude.

Authors:  Jong-Il Park; Seung-Woo Park; Min-Ji Kwon; Jeon Lee; Hong-Ju Kim; Chan-Hee Lee; Dong-Gu Shin
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

5.  Novel spatiotemporal processing tools for body-surface potential map signals for the prediction of catheter ablation outcome in persistent atrial fibrillation.

Authors:  Anna McCann; Adrian Luca; Patrizio Pascale; Etienne Pruvot; Jean-Marc Vesin
Journal:  Front Physiol       Date:  2022-09-29       Impact factor: 4.755

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.